Skip to main content
. 2014 Mar 1;1(1):34–38. doi: 10.5152/eurjrheum.2014.007

Table 1.

Clinical and demographic features of the NB patients with MLL

Cases Age/Sex BD findings Complaints at admission Physical examination MRI and/or CT lesions Biopsy Treatment Time of BD diagnosis (before or after neurologic manifestations)
Appenzeller et al. (1) 43/female OU
GU
Bilateral AU
Headache
Photophobia
Asthenia
Drowsiness, left arm and facial paresis, right eyelid ptosis Thalamic lesion with mass effect and contrast enhancement Gliosis with gemistocytic astrocytes Steroid CYC Before
Tuzgen et al. (4) 59/female OU, GU Left hemiparesis, lethargy, sensations of bad smell, headache Left hemiparesis, bilateral papilloedema vascular proliferation Right frontotemporal mass causing shift Reactive gliosis, panvasculitis, thrombosis, extensive infarction, Right frontotemporal craniotomy and subtotal excision After
Tuzgen et al. (4) 45/female OU, GU, monoarthritis Headache, right hemiparesis, somnolence Right hemiparesis Mass in the left mesodiencephalic junction Biopsy was not performed Steroid After
Heo et al. (5) 47/male OU, GU, uveitis Headache
Right side
Weakness
Vomiting
Right hemiparesis, dysarthria GdT1I showed ring enhancing lesions with internal hypointensities with subtle perilesional oedema at left side of the pons and parietal cortex Frequent perivascular lymphocytic cuffing, focal necrotic lesion, microglial nodules, foci of necrosis, foamy hystiocytic collections, reactive gliosis Steroid Before
Darmoul et al. (7) 38/Male Folliculitis Headache, aphasia, disturbed consciousness Right hemiplegia Pseudotumoral lesion in the left capsulo-thalamic region extending to the homolateral peduncle Biopsy was not performed Steroid Immunsupresive theraphy After
Imoto et al. (9) 50/male OU, GU, Skin eruption Dystasia dysbasia Left hemiparesis (+) left Babinski reflex dysarthria Low density area with significant mass effect in the right basal ganglia and thalamus with ring like enhancement following contrast injection Large numbers of chronic inflammatory cells mainly in the Virchow robin spaces Steroid After
Schmolck et al. (10) 39/male OU, GU Recurrent aseptic meningitis, diplopia, dysarthria Right sensorimotor hemiparesis with hyperreflexia, right sided dysmetria, disdiadochokinesis, ataxic gait Lesion in the left thalamus with patchy contrast enhancement and mass effect Steroid CYC Before
Matsuo et al. (11) 33/male OU, GU, EN Nausea, vomiting, headache Mild right hemiparesis Mass lesion at the left basal ganglia extending to the ventral side of the midbrain Mild reactive gliosis Steroid Before
Bennett et al. (12) 23/Male OU, GU, papulopustular rash Headache, fever, progressive right sided weakness Right homonymous hemianopia, right spastic hemiparesis Mass lesion involving the left temporal lobe Perivascular inflammatory infiltrate, no neoplasia Steroid, AZA Before
Yoshimura et al. (13) 41/Female OU, GU, EN Mental deterioration, right hemiparesis Poor mental activity, dysarthria and right hemiparesis Homogeneous hypodense lesion of the left lenticulothalamic region, mild mass effect Ruled out a tumour but did not show any specific diagnosis Steroid After
Ben Taarit et al.14 26/Female OU, GU Left hemiplegia Pseudotumoral lesion in the protuberance and the right cerebral pedicule Steroid After
Park et al.15 52/female OU, EN like skin lesion and arthritis Dizziness, nausea, vomiting Brun’s nystagmus T2WI showed high signal intensity in the right cerebellar hemisphere, post medulla, pons with an isosignal central mass, GdT1WI showed homogenously enhancing mass like lesion inside the T2 high signal intensity Biopsy was not performed Steroid AZA After
Presented case 27/Female OU, GU, skin lesions Headache, vomiting Left hemiparesis hyperintense lesion in the brainstem Biopsy was not performed Steroid AZA After

NB: neuro-Behçet; MLL: mass-like lesion; BD: Behçet’s disease; MRI: magnetic resonance imaging; CT: computerised tomography; OU: oral ulcer; GU: genital ulcer; AU: anterior uveitis; EN: erythema nodosum; CYC: cyclophosphamide; AZA: azathiopurin